Literature DB >> 23602223

Outpatient parenteral antibiotic therapy: principles and practice.

R A Seaton1, D A Barr.   

Abstract

Outpatient parenteral antimicrobial therapy (OPAT) refers to the administration of a parenteral antimicrobial in a non inpatient or ambulatory setting with the explicit aim of facilitating admission avoidance or early discharge. Whilst OPAT has predominantly been the domain of the infection specialist, the internal medicine specialist has a key role in service development and delivery as a component of broader ambulatory care initiatives such as "hospital at home". Main drivers for OPAT are patient welfare, reduction of risk of health care associated infection and cost-effective use of hospital resources. The safe practice of OPAT is dependent on a team approach with careful patient selection and antimicrobial management with programmed and adaptable clinical monitoring and assessment of outcome. Gram-positive infections, including cellulitis, bone and joint infection, bacteraemia and endocarditis are key infections potentially amenable to OPAT whilst resistant Gram-negative infections are of increasing importance. Ceftriaxone, teicoplanin, daptomycin and ertapenem lend themselves well to OPAT due to daily (or less frequent) bolus administration, although any antimicrobial may be administered if the patient is trained to administer and/or an appropriate infusion device is employed. Clinical experience from NHS Greater Glasgow and Clyde is presented to illustrate the key principles of OPAT as practised in the UK. Increasingly complex patients with multiple medical needs, the relative scarcity of inpatient resources and the broader challenge of ambulatory care and "hospital at home" will ensure the internal medicine specialist will have a key role in the future development of OPAT.
Copyright © 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ambulatory care; Bone and joint infection; Cellulitis; Endocarditis; Hospital at home

Mesh:

Substances:

Year:  2013        PMID: 23602223     DOI: 10.1016/j.ejim.2013.03.014

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  27 in total

1.  Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller : Proposal for novel treatment indications.

Authors:  Johannes Mischlinger; Heimo Lagler; Nicole Harrison; Michael Ramharter
Journal:  Wien Klin Wochenschr       Date:  2017-08-03       Impact factor: 1.704

2.  Cost-effectiveness of outpatient parenteral antibiotic therapy: a simulation modelling approach.

Authors:  A Vargas-Palacios; D M Meads; M Twiddy; C Czoski Murray; C Hulme; E D Mitchell; A Gregson; P Stanley; J Minton
Journal:  J Antimicrob Chemother       Date:  2017-08-01       Impact factor: 5.790

3.  OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.

Authors:  J Zhang; E Moore; R Bousfield
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-15       Impact factor: 3.267

4.  Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.

Authors:  Laura C Fanucchi; Sean M Murphy; Hilary Surratt; Shashi N Kapadia; Sharon L Walsh; James A Grubbs; Alice C Thornton; Paul Nuzzo; Michelle R Lofwall
Journal:  Ther Adv Infect Dis       Date:  2022-07-11

5.  Safety and efficacy of long-term outpatient ertapenem therapy.

Authors:  Zubair A Qureshi; Alveena Syed; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

6.  Stability of daptomycin reconstituted vials and infusion solutions.

Authors:  Javier Sánchez-Rubio Ferrández; Rocío Vázquez Sánchez; Damián Córdoba Díaz; Manuel Córdoba Díaz; María Carmen Lozano Estevan; Teresa Molina García
Journal:  Eur J Hosp Pharm       Date:  2016-03-14

7.  Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.

Authors:  Kavita P Bhavan; L Steven Brown; Robert W Haley
Journal:  PLoS Med       Date:  2015-12-15       Impact factor: 11.069

Review 8.  Managing an outpatient parenteral antibiotic therapy team: challenges and solutions.

Authors:  Jenana Halilovic; Cinda L Christensen; Hien H Nguyen
Journal:  Ther Clin Risk Manag       Date:  2014-06-18       Impact factor: 2.423

Review 9.  Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections.

Authors:  Armando Gonzalez-Ruiz; R Andrew Seaton; Kamal Hamed
Journal:  Infect Drug Resist       Date:  2016-04-15       Impact factor: 4.003

10.  Patient Characteristics and Outcomes of Outpatient Parenteral Antimicrobial Therapy: A Retrospective Study.

Authors:  Marie Yan; Marion Elligsen; Andrew E Simor; Nick Daneman
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-02-22       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.